Valuation: Dr. Reddy's Laboratories Limited

Market Cap 953B 9.98B 8.67B 8.05B 7.43B 13.99B 14.24B 95.35B 37.33B 473B 37.5B 36.67B 1,592B P/E 2027 *
25.3x
P/E 2028 * 19.7x
Enterprise Value 922B 9.65B 8.39B 7.79B 7.18B 13.53B 13.77B 92.19B 36.09B 458B 36.25B 35.46B 1,539B EV / Sales 2027 *
2.62x
EV / Sales 2028 * 2.3x
Free-Float
70.08%
Yield 2027 *
0.67%
Yield 2028 * 0.74%
1 day+0.65%
1 week-1.26%
Current month-15.11%
1 month-15.11%
3 months-12.94%
6 months-5.47%
Current year-9.38%
1 week 1,129.1
Extreme 1129.1
1,165
1 month 1,080.05
Extreme 1080.05
1,389.5
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2019
Director of Finance/CFO - 31/07/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 12/05/2014
Chairman 65 01/04/2013
Director/Board Member 65 24/10/2018
Date Insider Type Main position Quantity % Market Cap.
18/12/25 Other

Chairman

85,738,125 10.2732%
18/12/25 Other

Director

12,717,090 1.5238%
18/12/25 Other

Director

27,618,385 3.3092%
Change 5-day change 1-year change 3-year change Capi.($)
+0.62%-1.26%-10.82%+2.00% 9.98B
-4.55%-2.61%+51.95%+151.91% 1,030B
-3.66%-1.33%+52.95%+46.62% 617B
-2.24%+0.19%+35.97%+70.64% 455B
+0.75%+0.42%+38.70%+31.78% 350B
+0.87%+0.82%+35.83%+40.49% 299B
+0.84%+1.33%+13.37%+14.77% 265B
+0.07%+3.23%+5.23%-39.40% 225B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 163B
Average -0.36%+4.01%+26.62%+45.36% 362.27B
Weighted average by Cap. -0.65%+4.85%+38.56%+71.91%

Financials

2027 *2028 *
Net sales 352B 3.69B 3.2B 2.97B 2.74B 5.17B 5.26B 35.2B 13.78B 175B 13.84B 13.54B 588B 393B 4.11B 3.57B 3.32B 3.06B 5.76B 5.87B 39.29B 15.38B 195B 15.45B 15.11B 656B
Net income 37.27B 390M 339M 315M 290M 547M 557M 3.73B 1.46B 18.51B 1.47B 1.43B 62.25B 49.1B 514M 447M 415M 383M 721M 734M 4.91B 1.92B 24.39B 1.93B 1.89B 82.01B
Net Debt -31.58B -331M -287M -267M -246M -464M -472M -3.16B -1.24B -15.69B -1.24B -1.22B -52.75B -51.62B -541M -470M -436M -402M -758M -771M -5.16B -2.02B -25.64B -2.03B -1.99B -86.21B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
31/07/26 1,151.40 +0.62% 39,057
30/07/26 ₹1,144.35 +0.10% 73,766
29/07/26 ₹1,143.20 +0.66% 104,888
28/07/26 ₹1,135.65 -1.33% 103,848
27/07/26 ₹1,150.90 -0.15% 74,148
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
40
Last Close Price
1,144.35INR
Average target price
1,262.63INR
Spread / Average Target
+10.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock